Valencia Technologies
Valencia
About Valencia Technologies
Valencia Technologies develops neuromodulation devices to treat urinary incontinence. The company manufactures and markets the eCoin system, an FDA-approved subcutaneous implantable tibial nerve stimulator for Urge Urinary Incontinence (UUI). The eCoin device, a small neurostimulator implanted under the skin near the ankle, delivers automatic tibial nerve stimulation through a dome-shaped field. The procedure is minimally invasive, requiring only local anesthesia. The device is designed to function without external remotes, lead wires, recharge requirements, or the need for general anesthesia during placement.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: Less than $1M
- Total funding: $46.0M
- Funding stage: M&A
- Last round: Series Unknown (Feb 2025)
- Website: valenciatechnologies.com
- Phone: 661-775-1414
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/valencia-technologies-59742 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.